UPC Analytics
ENDE
Overview · Filed: Aug 29, 2024

UPC_CFI_374/2024

NOVEL ANTITUMORAL USE OF CABAZITAXEL

Parent infringement case:UPC_CFI_147/2024

RevocationCounter Claim for RevocationMunich LDCounter claim for revocationCase Closed
OverviewDecisionsDocumentsTimeline
Parties

Claimants

  • betapharm Arzneimittel GmbH
  • Dr Reddy's Srl
  • Reddy Pharma SAS
Reps: Frédéric Chevallier (McDermott Will & Emery)

Respondents

Reps: Jules Fabre (Taylor Wessing); Daniel Hoppe (Bonabry); Christian Meyer (Maiwald); Anja Lunze (Taylor Wessing)
Judges
  • Matthias Zigann
  • Alima Zana
  • Tobias Pichlmaier
Patents
  • EP2493466
  • EP 2 493 466
CPC codes: A61K38/193, A61K31/573, A61P35/04, A61K31/164, A61K31/56, A61P43/00, A61P13/08, A61P15/00, A61K31/337, A61P35/00, A61K45/06, A61P25/16

Technology area: Pharmaceuticals · Small Molecule

Sector: Pharmaceutical & Medical

Outcome
Procedural onlyProcedural only (no substantive ruling yet)
Filed: Aug 29, 2024
First decided: Dec 12, 2025
Language: English
Open on UPC Registry